Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Alcon Research Tufts University
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00312338

Purpose

Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora

Condition	Intervention	Phase
Bacterial Conjunctivitis	Drug: Polytrim or similar	Phase IV

Study Type:	Interventional
Study Design:	Non-Randomized, Single Blind, Historical Control, Parallel Assignment
Official Title:	Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Susceptability changes in specified bacteria in the nasal cavity, oropharynx or skin when measured [ Time Frame: Time ]

Estimated Enrollment:	134
Study Start Date:	April 2006

Eligibility

Criteria

Inclusion Criteria:

Patients from 1 to 13 years of age that have diagnosis of bacterial conjunctivitis in either or both eyes (for < 3 days duration) based on clinical observation; matched healthy controls

Exclusion Criteria:

Cannot have had bacterial conjunctivitis symptoms as reported by parent for > 2 days

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00312338

Locations

United States, Texas
Multiple Locations
Fort Worth, Texas, United States, 76134

Sponsors and Collaborators

Alcon Research

Tufts University

Investigators

Principal Investigator:

Steven J. Lichtenstein, M.D.

Investigator / Contact

More Information

Study ID Numbers:	CMS-05-11
Study First Received:	April 4, 2006
Last Updated:	September 10, 2007
ClinicalTrials.gov Identifier:	NCT00312338
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Bacterial Infections
Eye Infections, Bacterial
Conjunctivitis, Bacterial
Eye Diseases

Eye Infections
Conjunctivitis
Conjunctival Diseases

Additional relevant MeSH terms:

Infection

ClinicalTrials.gov processed this record on January 16, 2009